Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Earnings Per Share Diluted of $0.07 (loss) per share for the year ending 2024.
- NORTHWEST BIOTHERAPEUTICS INC showed a decrease of -16.7% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from NORTHWEST BIOTHERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2019 to 2024), NORTHWEST BIOTHERAPEUTICS INC's Earnings Per Share Diluted has declined by 75.0%.
- Historical annual values: Fiscal year 2024: $0.07 (loss) per share | Fiscal year 2023: $0.06 (loss) per share | Fiscal year 2022: $0.10 (loss) per share | Fiscal year 2021: $0.06 (loss) per share | Fiscal year 2020: $0.73 (loss) per share | Fiscal year 2019: $0.04 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: